Cargando…

Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol

A recent consensus guideline recommends migrating the therapeutic drug monitoring practice for intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection from the traditional trough-based approach to the Bayesian approach based on area under curve to improve cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Ka Ho Matthew, Lui, Chung Yan Grace, Wu, Ka Lun Alan, Chen, Jason, Cheung, Yin Ting, Lam, Tai Ning Teddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070875/
https://www.ncbi.nlm.nih.gov/pubmed/35511796
http://dx.doi.org/10.1371/journal.pone.0267894
_version_ 1784700725392048128
author Hui, Ka Ho Matthew
Lui, Chung Yan Grace
Wu, Ka Lun Alan
Chen, Jason
Cheung, Yin Ting
Lam, Tai Ning Teddy
author_facet Hui, Ka Ho Matthew
Lui, Chung Yan Grace
Wu, Ka Lun Alan
Chen, Jason
Cheung, Yin Ting
Lam, Tai Ning Teddy
author_sort Hui, Ka Ho Matthew
collection PubMed
description A recent consensus guideline recommends migrating the therapeutic drug monitoring practice for intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection from the traditional trough-based approach to the Bayesian approach based on area under curve to improve clinical outcomes. To support the implementation of the new strategy for hospitals under Hospital Authority, Hong Kong, this study is being proposed to (1) estimate and validate a population pharmacokinetic model of intravenous vancomycin for local adults, (2) develop a web-based individual dose optimization application for clinical use, and (3) evaluate the performance of the application by comparing the treatment outcomes and clinical satisfaction against the traditional approach. 300 adult subjects prescribed with intravenous vancomycin and not on renal replacement therapy will be recruited for population pharmacokinetic model development and validation. Sex, age, body weight, serum creatinine level, intravenous vancomycin dosing records, serum vancomycin concentrations etc. will be collected from several electronic health record systems maintained by Hospital Authority. Parameter estimation will be performed using non-linear mixed-effect modeling techniques. The web-based individual dose optimization application is based on a previously reported application and is built using R and the package shiny. Data from another 50 subjects will be collected during the last three months of the study period and treated as informed by the developed application and compared against historical control for clinical outcomes. Since the study will incur extra blood-taking procedures from patients, informed consent is required. Other than that, recruited subjects should receive medical treatments as usual. Identifiable patient data will be available only to site investigators and clinicians in each hospital. The study protocol and informed consent forms have been approved by the Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (reference number: NTEC-2021-0215) and registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2100048714).
format Online
Article
Text
id pubmed-9070875
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90708752022-05-06 Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol Hui, Ka Ho Matthew Lui, Chung Yan Grace Wu, Ka Lun Alan Chen, Jason Cheung, Yin Ting Lam, Tai Ning Teddy PLoS One Study Protocol A recent consensus guideline recommends migrating the therapeutic drug monitoring practice for intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection from the traditional trough-based approach to the Bayesian approach based on area under curve to improve clinical outcomes. To support the implementation of the new strategy for hospitals under Hospital Authority, Hong Kong, this study is being proposed to (1) estimate and validate a population pharmacokinetic model of intravenous vancomycin for local adults, (2) develop a web-based individual dose optimization application for clinical use, and (3) evaluate the performance of the application by comparing the treatment outcomes and clinical satisfaction against the traditional approach. 300 adult subjects prescribed with intravenous vancomycin and not on renal replacement therapy will be recruited for population pharmacokinetic model development and validation. Sex, age, body weight, serum creatinine level, intravenous vancomycin dosing records, serum vancomycin concentrations etc. will be collected from several electronic health record systems maintained by Hospital Authority. Parameter estimation will be performed using non-linear mixed-effect modeling techniques. The web-based individual dose optimization application is based on a previously reported application and is built using R and the package shiny. Data from another 50 subjects will be collected during the last three months of the study period and treated as informed by the developed application and compared against historical control for clinical outcomes. Since the study will incur extra blood-taking procedures from patients, informed consent is required. Other than that, recruited subjects should receive medical treatments as usual. Identifiable patient data will be available only to site investigators and clinicians in each hospital. The study protocol and informed consent forms have been approved by the Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (reference number: NTEC-2021-0215) and registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2100048714). Public Library of Science 2022-05-05 /pmc/articles/PMC9070875/ /pubmed/35511796 http://dx.doi.org/10.1371/journal.pone.0267894 Text en © 2022 Hui et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
Hui, Ka Ho Matthew
Lui, Chung Yan Grace
Wu, Ka Lun Alan
Chen, Jason
Cheung, Yin Ting
Lam, Tai Ning Teddy
Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol
title Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol
title_full Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol
title_fullStr Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol
title_full_unstemmed Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol
title_short Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol
title_sort multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in hong kong: a study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070875/
https://www.ncbi.nlm.nih.gov/pubmed/35511796
http://dx.doi.org/10.1371/journal.pone.0267894
work_keys_str_mv AT huikahomatthew multicenterprospectivepopulationpharmacokineticstudyandtheperformanceofwebbasedindividualdoseoptimizationapplicationofintravenousvancomycinforadultsinhongkongastudyprotocol
AT luichungyangrace multicenterprospectivepopulationpharmacokineticstudyandtheperformanceofwebbasedindividualdoseoptimizationapplicationofintravenousvancomycinforadultsinhongkongastudyprotocol
AT wukalunalan multicenterprospectivepopulationpharmacokineticstudyandtheperformanceofwebbasedindividualdoseoptimizationapplicationofintravenousvancomycinforadultsinhongkongastudyprotocol
AT chenjason multicenterprospectivepopulationpharmacokineticstudyandtheperformanceofwebbasedindividualdoseoptimizationapplicationofintravenousvancomycinforadultsinhongkongastudyprotocol
AT cheungyinting multicenterprospectivepopulationpharmacokineticstudyandtheperformanceofwebbasedindividualdoseoptimizationapplicationofintravenousvancomycinforadultsinhongkongastudyprotocol
AT lamtainingteddy multicenterprospectivepopulationpharmacokineticstudyandtheperformanceofwebbasedindividualdoseoptimizationapplicationofintravenousvancomycinforadultsinhongkongastudyprotocol